Jennison Associates LLC reduced its stake in shares of Chemours Company (The) (NYSE:CC) by 11.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 444,063 shares of the specialty chemicals company’s stock after selling 56,796 shares during the quarter. Jennison Associates LLC owned about 0.24% of Chemours Company (The) worth $22,474,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Acrospire Investment Management LLC boosted its position in shares of Chemours Company (The) by 3.4% during the second quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock valued at $117,000 after buying an additional 100 shares during the period. Cypress Capital Management LLC boosted its position in shares of Chemours Company (The) by 0.5% during the second quarter. Cypress Capital Management LLC now owns 31,393 shares of the specialty chemicals company’s stock valued at $1,190,000 after buying an additional 155 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Chemours Company (The) by 0.6% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,921 shares of the specialty chemicals company’s stock valued at $1,021,000 after buying an additional 167 shares during the period. Commerce Bank boosted its position in shares of Chemours Company (The) by 3.0% during the second quarter. Commerce Bank now owns 7,158 shares of the specialty chemicals company’s stock valued at $272,000 after buying an additional 206 shares during the period. Finally, World Asset Management Inc boosted its position in shares of Chemours Company (The) by 4.0% during the second quarter. World Asset Management Inc now owns 15,652 shares of the specialty chemicals company’s stock valued at $594,000 after buying an additional 597 shares during the period. 72.90% of the stock is currently owned by institutional investors.

Shares of Chemours Company (NYSE:CC) opened at $51.55 on Friday. The company has a quick ratio of 1.63, a current ratio of 2.19 and a debt-to-equity ratio of 5.07. The stock has a market capitalization of $9,193.35, a P/E ratio of 17.61, a P/E/G ratio of 0.86 and a beta of 3.59. Chemours Company has a twelve month low of $20.76 and a twelve month high of $58.08.

Chemours Company (The) (NYSE:CC) last issued its quarterly earnings data on Thursday, November 2nd. The specialty chemicals company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.01 by $0.11. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. Chemours Company (The) had a net margin of 4.86% and a return on equity of 116.80%. Chemours Company (The)’s revenue for the quarter was up 13.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.61 earnings per share. research analysts expect that Chemours Company will post 3.73 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 15th. Investors of record on Monday, November 20th will be paid a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date is Friday, November 17th. Chemours Company (The)’s dividend payout ratio (DPR) is 8.28%.

TRADEMARK VIOLATION WARNING: This piece was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/11/17/jennison-associates-llc-has-22-47-million-holdings-in-chemours-company-the-cc.html.

In related news, insider E Bryan Snell sold 13,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $49.35, for a total value of $641,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP David C. Shelton sold 5,908 shares of the business’s stock in a transaction that occurred on Friday, October 13th. The stock was sold at an average price of $56.01, for a total transaction of $330,907.08. Following the completion of the transaction, the senior vice president now directly owns 47,356 shares of the company’s stock, valued at approximately $2,652,409.56. The disclosure for this sale can be found here. Insiders sold 76,520 shares of company stock valued at $4,008,293 in the last three months. 1.14% of the stock is currently owned by insiders.

Several research analysts have issued reports on CC shares. Citigroup Inc. boosted their target price on Chemours Company (The) from $45.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 4th. Zacks Investment Research lowered Chemours Company (The) from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 18th. UBS AG boosted their price target on Chemours Company (The) from $50.00 to $59.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. J P Morgan Chase & Co boosted their price target on Chemours Company (The) to $55.00 and gave the company an “overweight” rating in a report on Friday, August 4th. Finally, Jefferies Group LLC boosted their price target on Chemours Company (The) to $60.00 and gave the company a “buy” rating in a report on Thursday, August 3rd. One investment analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $53.89.

Chemours Company (The) Company Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemours Company (The) (NYSE:CC).

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Stock Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related stocks with our FREE daily email newsletter.